期刊文献+

血浆NT-proBNP和D-D在心房颤动患者中的变化及意义 被引量:2

The Changes and Significance of Plasma NT-proBNP and D-D in Patients with Atrial Fibrillation
下载PDF
导出
摘要 目的:观察非瓣膜性心房颤动患者血浆N一末端脑钠肽前体(NT-proBNP)和D二聚体(D-dimer,D-D)的变化,探讨NT-proBNP及血栓前状态在心房颤动发生、发展与维持中的作用。方法:分别测定86例心房颤动患者(房颤组)和非房颤患者(对照组)血浆NT-proBNP和D-D。观察NT—proBNP和D-D与房颤的关系。结果:房颤组血浆NT-proBNP和D-D均明显高于对照组(P<0.05与P<0.01)。NT-proBNP和D-D在阵发性房颤组与持续性房颤组间差异无统计学意义(P>0.05)。结论:NT-proBNP及血栓前状态在房颤的发生、发展与维持中可能起重要作用。 Objective To observe the changes of NT-proBNP and D-Dimer(D-D) in patients with atrial fibrillation, and to investigate the roles of NT-proBNP and prothrombotic state(PTS) in the initiation, progression and persistence of atrial fibrillation. Methods Plasma NT-proBNP and D-D were determined in 86 patients with atrial fibrillation and controls (non-fibrillation patients) respectively. Basides, to observe NT-proBNP and D-D relationship with atrial fibrillation. Results The levels of plasma NT-proBNP and D- D in the patients with atrial fibrillation were significant higher than that of control group(P 〈 0.05 and P 〈 0.01 respectively). There was no diffdrence of NT-proBNP and D-D between persistent atrial fibrillation group and paroxysmal atrial fibrillation group. Conclusions NT-proBNP and PTS may play an important role in the initiation,progression and persistence of atrial fibrillation.
出处 《放射免疫学杂志》 CAS 2012年第1期56-58,共3页 Journal of Radioimmanology
关键词 心房颤动 N-末端脑钠肽前体 D-二聚体 血栓前状态 atrial fibrillation,NT-proBNP,D-Dimer(D-D), prothrombotic state(PTS)
  • 相关文献

参考文献5

  • 1Patel JB,Valencik ML,Pritebeit AM,et al.Coidiac-specific at-tenuation of natriutetic peptide A receptor activity accentuates advene cardiac remodeling and mortality in response to pressure overload[J].Am J Pbysiol Heart Circ Physiol,2005,289(2):777-784.
  • 2Tsuchida K,Tanabe K.Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion[J].J Cardiol,2004,44 (1):1-11.
  • 3杨志宏,洪梅,秦永文.非瓣膜性房颤患者血栓性脑卒中的预防[J].国外医学(心血管疾病分册),2005,32(1):1-3. 被引量:14
  • 4Jafn SM,Eberhard F,Mammen MD,et al.Effects of warfarin on markers of hypercoagulability in patients with heart failure[J].Heart J,1997,134(1):27-36.
  • 5Sohara H,Amltanl S,Kurose M.et al.Atrial fibrifation activates platelets and coagulation in a time-dependent manner:A study in patients with paroxysmal fibrillation[J].J Am Coll Cardil,1997,29(1).106-112.

二级参考文献20

  • 1Kannel WB, Wolf PA,Benjamin EJ, et al. Am J Cardiol,1998; 82(8A): 2N~9N.
  • 2Anonymous. Lancet, 1994;343(8899) :687~691.
  • 3Corrado G, Tadeo G,Beretta S, et al. Chest, 1999;115(1):140~143.
  • 4Li Saw Hee FL,Blann AD,Lip GYH. Stroke, 2000;31(4):828~833.
  • 5Van Walraven C, Hart RG, Singer DE, et al. JAMA, 2002;288(19) :2 441~2 448.
  • 6Bungard TJ, Ghali WA, Teo KK, et al. Arch Intern Med,2000;160(1) :41~46.
  • 7Levine MN,Raskob G,Landefeld S, et al. Chest,2001;119(Suppl 1) :108S~121S.
  • 8Olsson SB. Lancet, 2003;362(9397):1 691~1 698.
  • 9Halperin JL, Gomberg-Maitland M. J Am Coll Cardiol, 2003 ;42(7):1 259~1 261.
  • 10Bonow RO, Carabello B, de Leon AC Jr, et al. J Am Coll Cardiol, 1998; 32(5):1 486~1 582.

共引文献13

同被引文献15

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部